The ability of acetaminophen to inhibit MPO activity and reduce the production of potent oxidants such as hypobromous acid (HOBr) and hypochlorous acid (HOCl) may partially explain its potential protective effects in ischemic stroke patients (Morgan et al., 2011). This evidence concerns the gene MPO and ischemic stroke.